N-(4-fluorobenzyl)-5-(2-{[2-methoxy-4-(2-oxa-6-azaspiro[3.3]hept-6-yl-carbonyl)phenyl]amino}[1,2,4]triazolo[1,5-a]pyridin-6-yl)pyridine-2-carboxamide | 1352620-70-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三唑并吡啶类
• 英文名称: N-(4-fluorobenzyl)-5-(2-{[2-methoxy-4-(2-oxa-6-azaspiro[3.3]hept-6-yl-carbonyl)phenyl]amino}[1,2,4]triazolo[1,5-a]pyridin-6-yl)pyridine-2-carboxamide
• 英文别名: US9555022, Example 13.01；N-[(4-fluorophenyl)methyl]-5-[2-[2-methoxy-4-(2-oxa-6-azaspiro[3.3]heptane-6-carbonyl)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]pyridine-2-carboxamide
• CAS: 1352620-70-2
• 化学式: C₃₂H₂₈FN₇O₄
• 分子量: 593.617
• InChiKey: MJSQXTLHEQLTQL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  44
• 可旋转键数：
  8
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  123
• 氢给体数：
  2
• 氢受体数：
  9

文献信息

• [EN] SUBSTITUTED TRIAZOLOPYRIDINES<br/>[FR] TRIAZOLOPYRIDINES SUBSTITUÉES
  申请人：BAYER PHARMA AG

  公开号：WO2011157688A1

  公开（公告）日：2011-12-22

  The present invention relates to substituted triazolopyridine compounds of general formula (I) : in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease of uncontrolled cell growth, proliferation and/or survival as well as to the use of intermediate compounds for the preparation of said compounds.

  本发明涉及通式（I）的取代三唑吡啶化合物，其中R1、R2、R3、R4和R5如描述和索赔中所述，以及制备所述化合物的方法，包括所述化合物的药物组合物和组合物，用于制造用于治疗或预防细��生长、增殖和/或存活失控疾病的药物组合物以及用于制备所述化合物的中间化合物的用途。
• Substituted Triazolopyridines
  申请人：Schulze Volker

  公开号：US20130156756A1

  公开（公告）日：2013-06-20

  The present invention relates to substituted triazolopyridine compounds of general formula (I): in which R 1 , R 2 , R 3 , R 4 , and R 5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease of uncontrolled cell growth, proliferation and/or survival as well as to the use of intermediate compounds for the preparation of said compounds.

  本发明涉及通式（I）的取代三唑吡啶化合物，其中R1、R2、R3、R4和R5如描述和权利要求中所给出，以制备所述化合物的方法，包括所述化合物的制药组合物和组合物，以及用于制造治疗或预防不受控制的细胞生长，增殖和/或存活疾病的制药组合物的所述化合物的用途，以及用于制备所述化合物的中间化合物的用途。
• SUBSTITUTED TRIAZOLOPYRIDINES
  申请人：Bayer Intellectual Property GmbH

  公开号：EP2582699A1

  公开（公告）日：2013-04-24
• US9555022B2
  申请人：——

  公开号：US9555022B2

  公开（公告）日：2017-01-31